SCHEMBL4455502

SCHEMBL4455502

CCCCCCCCCO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(NC(=O)c3ccccc3)ncnc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC29A1 Q99808 3/20 0.55
ADORA1 P30542 4/20 0.54
ADORA3 P0DMS8 2/20 0.53
ADORA2A P29274 1/20 0.53
ADORA2B P29275 1/20 0.53
LMNA P02545 2/20 0.52
ALDH1A1 P00352 1/20 0.52
GLA P06280 1/20 0.52
PMP22 Q01453 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
NPC1 O15118 1/20 0.52
NPY1R P25929 1/20 0.52
HTT P42858 1/20 0.52
NPY2R P49146 1/20 0.52
RAB9A P51151 1/20 0.52
RXFP1 Q9HBX9 1/20 0.52
CYP1A2 P05177 1/20 0.52
TSHR P16473 1/20 0.52
NFKB1 P19838 1/20 0.52
MAPK1 P28482 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7245383 1.00 SLC29A1 (0.55) SLC29A1ADORA1ADORA3ADORA2AADORA2B
SCHEMBL9006338 0.99 SLC29A1 (0.56) SLC29A1ADORA1ADORA3ADORA2AADORA2B
SCHEMBL6896950 0.99 SLC29A1 (0.56) SLC29A1ADORA1ADORA3ADORA2AADORA2B
SCHEMBL6898740 0.97 ADORA1 (0.55) SLC29A1ADORA1ADORA3ADORA2AADORA2B
SCHEMBL6897956 0.94 ADORA1 (0.56) SLC29A1ADORA1ADORA3ADORA2AADORA2B
SCHEMBL6899424 0.91 ADORA1 (0.56) SLC29A1ADORA1ADORA3ADORA2AADORA2B
SCHEMBL6899430 0.91 ADORA1 (0.56) SLC29A1ADORA1ADORA3ADORA2AADORA2B
SCHEMBL38653713 0.90 ADORA1 (0.56) SLC29A1ADORA1ADORA3ADORA2AADORA2B
SCHEMBL19407591 0.90 ADORA1 (0.56) SLC29A1ADORA1ADORA3ADORA2AADORA2B
SCHEMBL7064871 0.90 ADORA1 (0.56) SLC29A1ADORA1ADORA3ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090198047-A1 2'-Modified Oligonucleotides ISIS PHARMACEUTICALS, INC. (US) 2009-08-06 US disclosed
US-20080032945-A1 2'-MODIFIED OLIGONUCLEOTIDES ISIS PHARMACEUTICALS, INC. (US) 2008-02-07 US disclosed
US-7138517-B2 Sugar modified oligonucleotides ISIS PHARMACEUTICALS, INC. (US) 2006-11-21 US disclosed
US-20030187240-A1 2' -modified oligonucleotides ISIS PHARMACEUTICALS, INC. 2003-10-02 US disclosed
US-6531584-B1 Nuclease resistant oligonucleotide analogs; DNA or RNA modulation; diagnosis, thearpy of viral diseases ISIS PHARMACEUTICALS, INC. 2003-03-11 US disclosed
US-20030004325-A1 Sugar modified oligonucleotides ISIS PHARMACEUTICALS, INC. 2003-01-02 US disclosed
US-6399754-B1 CONTAINING SULFOPHOSPHATE GROUP ISIS PHARMACEUTICALS, INC. 2002-06-04 US disclosed